Joe is a member of the Life Sciences Health Industry Group, practicing in the area of health care regulatory law. His practice focuses on counseling health care manufacturers, distributors and providers on reimbursement, regulatory, and fraud and abuse issues.

For more than 20 years, Joe has provided analysis and counseling on behalf of manufacturers with respect to government pricing matters including: the Medicaid drug rebate statute, the Veterans Health Care Act’s drug pricing standards, the federal anti-kickback statute, and other state and federal laws relating to the promotion of prescription drugs and medical devices. In this area, he has assisted with day-to-day methodological counseling, contract pricing strategies, recalculation matters, government pricing investigations, and due diligence on government pricing matters. Joe has been listed in the LMG Life Sciences Guide since its inception as a life science “star” in the pricing and reimbursement area.

In addition, Joe regularly works with manufacturers on health care fraud and abuse compliance, including regulatory, transactional and litigation matters. He has helped companies in various aspects of compliance program development and financial relationship reporting, as well as day-to-day counseling, the preparation of OIG advisory opinion requests, responses to subpoenas and other internal and external investigations and conducting health care regulatory due diligence in the context of product and company acquisitions.

Washington, D.C. office of our client seeks intellectual property attorney with 2-3 years of patent litigation experience. The candidate must have an electrical engineering or computer science backgro...

Barbara A. Fitzgerald

Barbara J. Shander

Ms. Shander advises public and private company clients as well as private equity funds, with an emphasis on mergers and acquisitions, dispositions, and financing transactions.

Barton W S Bassett

Barton W.S. Bassett is the leader of Morgan Lewis's Tax Practice. Mr. Bassett's practice focuses on international tax planning for both the outbound operations of U.S. multinationals and the inbound operations of foreign multinationals.